Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paradoxical resolution of refractory subretinal fluid in dome-shaped macula after discontinuation of anti-VEGF therapy.

BMJ case reports·2026
Same author

Genomic Copy Number Variants Associated With Strabismus and Amblyopia in the All of Us Research Program.

Investigative ophthalmology & visual science·2026
Same author

Extrapedicular approach for basivertebral nerve radiofrequency ablation: a conceptual review.

Journal of orthopaedic surgery and research·2026
Same author

Brachial Plexopathy Following Rapid Weight Loss from Tirzepatide: A Case Report.

Pain medicine case reports·2026
Same author

Cost-effectiveness of Adding Remplissage to Bankart Repair for On-Track Hill-Sachs Lesions: A Markov Decision Analysis.

The American journal of sports medicine·2026
Same author

Evaluating Whether Melatonin Impacts Postoperative Sleep Following Total Joint Arthroplasty: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Cureus·2026

Related Experiment Video

Updated: Jul 3, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
05:00

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

14.8K

Intense Pulsed Light Therapy for Post-LASIK Dry Eye: A Systematic Review and Meta-Analysis.

Trevor Lin1, Austin Chao1, Megan Kou2

  • 1Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|April 29, 2026
PubMed
Summary
This summary is machine-generated.

Intense pulsed light (IPL) therapy may alleviate subjective dry eye symptoms after laser-assisted in situ keratomileusis (LASIK) surgery. However, objective clinical improvements require further investigation in larger, controlled studies.

Keywords:
LASIKdry eye syndromeintense pulsed lightmeibomian gland dysfunctionpost-LASIK dry eyetear breakup time

More Related Videos

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

1.1K
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

1.0K

Related Experiment Videos

Last Updated: Jul 3, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
05:00

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

14.8K
Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

1.1K
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

1.0K

Area of Science:

  • Ophthalmology
  • Medical Technology

Background:

  • Dry eye syndrome (DES) is a common complication following laser-assisted in situ keratomileusis (LASIK).
  • Intense pulsed light (IPL) therapy is being explored as a treatment for DES.
  • Managing post-LASIK DES is crucial for patient satisfaction and visual outcomes.

Purpose of the Study:

  • To systematically review and meta-analyze the efficacy and safety of IPL therapy for DES after LASIK.
  • To assess the impact of IPL on both subjective and objective measures of dry eye.
  • To identify the current evidence base and limitations for IPL in post-LASIK DES management.

Main Methods:

  • A comprehensive literature search was performed across major databases for relevant studies.
  • Included studies involved IPL treatment for post-LASIK DES, analyzing outcomes like OSDI, TBUT, and meibomian gland function.
  • Random-effects meta-analyses were conducted to synthesize findings from four included studies (146 eyes).

Main Results:

  • IPL therapy showed a statistically significant improvement in patient-reported dry eye symptoms (OSDI score).
  • Improvements in objective measures (TBUT, ATU, corneal staining, lipid layer, meibomian gland function) were directionally positive but not statistically significant.
  • Substantial between-study heterogeneity and limited follow-up duration (0-24 weeks) were noted.

Conclusions:

  • IPL therapy may offer benefits for subjective dry eye symptoms post-LASIK.
  • The evidence for objective clinical improvement with IPL in this context remains uncertain.
  • Larger, controlled trials with standardized protocols and longer follow-up are needed to confirm IPL's role.